Monday , January 24 2022

Corona … a popular medicine that reduces the risk of death for patients with the virus!


A new British study has shown that the anti-inflammatory drug “tocilizumab” reduces the risk of death of critically ill patients by the “Corona” virus, according to the French newspaper “Le Monde”.

For its part, “” network stated that “tocilizumab”, which is usually given for rheumatoid arthritis, could help save the life of one of the 25 people admitted to hospital due to acute infection with the virus.

However, the UK “recovery” experience has shown that the drug reduces the need for artificial respiration, and can also shorten the time the patient spends in the hospital up to 10 days.

It is noteworthy that this drug has undergone many experiments in the past, and the results have shown that it treats patients with severe cases of “Corona”, and researchers in Britain and the Netherlands said that it was “a very great result”.

Tocilizumab targets the immune system, which may be overactive in some patients. In some cases, the exaggerated response of the immune system, and not the virus itself, is the source of the danger that life can take, according to what the British Broadcasting Corporation “BBC” said in an earlier report.

Source link